<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Duan S</submitter><funding>Ministry of Science and Technology of the People&amp;apos;s Republic of China</funding><funding>National Natural Science Foundation of China</funding><pagination>386-91</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4416425</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(4)</volume><pubmed_abstract>Analogues of the natural product (-)-arctigenin, an activator of adenosine monophosphate activated protein kinase, were prepared in order to evaluate their effects on 2-deoxyglucose uptake in L6 myotubes and possible use in ameliorating metabolic disorders. Racemic arctigenin 2a was found to display a similar uptake enhancement as does (-)-arctigenin. As a result, the SAR study was conducted utilizing racemic compounds. The structure-activity relationship study led to the discovery of key substitution patterns on the lactone motif that govern 2-deoxyglucose uptake activities. The results show that replacement of the para-hydroxyl group of the C-2 benzyl moiety of arctigenin by Cl has a pronounced effect on uptake activity. Specifically, analogue 2p, which contains the p-Cl substituent, sti</pubmed_abstract><journal>ACS medicinal chemistry letters</journal><pubmed_title>Design and synthesis of novel arctigenin analogues for the amelioration of metabolic disorders.</pubmed_title><pmcid>PMC4416425</pmcid><funding_grant_id>2102ZX09103101-062</funding_grant_id><funding_grant_id>81202570</funding_grant_id><funding_grant_id>81225022</funding_grant_id><pubmed_authors>Ren W</pubmed_authors><pubmed_authors>Huang S</pubmed_authors><pubmed_authors>Hu Y</pubmed_authors><pubmed_authors>Zeng L</pubmed_authors><pubmed_authors>Feng Y</pubmed_authors><pubmed_authors>Leng Y</pubmed_authors><pubmed_authors>Duan S</pubmed_authors><pubmed_authors>Gong J</pubmed_authors><pubmed_authors>Shen Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design and synthesis of novel arctigenin analogues for the amelioration of metabolic disorders.</name><description>Analogues of the natural product (-)-arctigenin, an activator of adenosine monophosphate activated protein kinase, were prepared in order to evaluate their effects on 2-deoxyglucose uptake in L6 myotubes and possible use in ameliorating metabolic disorders. Racemic arctigenin 2a was found to display a similar uptake enhancement as does (-)-arctigenin. As a result, the SAR study was conducted utilizing racemic compounds. The structure-activity relationship study led to the discovery of key substitution patterns on the lactone motif that govern 2-deoxyglucose uptake activities. The results show that replacement of the para-hydroxyl group of the C-2 benzyl moiety of arctigenin by Cl has a pronounced effect on uptake activity. Specifically, analogue 2p, which contains the p-Cl substituent, sti</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Apr</publication><modification>2025-04-26T07:55:25.901Z</modification><creation>2019-03-27T01:50:49Z</creation></dates><accession>S-EPMC4416425</accession><cross_references><pubmed>25941553</pubmed><doi>10.1021/acsmedchemlett.5b00007</doi></cross_references></HashMap>